ITOCNCMHealthcare·Medical Devices#127 in industry

iTonic Holdings Ltd.

-22.1% · 90d

$0.41

+0.03 (+8.29%)

News

(1)

April 2026

Apr 23, 20265 days ago6-KHealthcare

iTonic Holdings Ltd — 6-K Filing

ITOCiTonic Holdings Ltd

# 🧾 What This Document Is This is a **press release** filed with the SEC as a 6-K report. It’s a formal announcement to investors that iTonic Holdings Ltd has received a critical extension from the Nasdaq stock exchange. Think of it as a " lifeline" notice. # 📢 The Big News: A Compliance Extensio

Read summaryView on SEC EDGAR

Key Data

Market Cap$6.9M

Open$0.38

Prev Close$0.37

Day Range$0.38 – $0.44

52W Range$0.25 – $32.00

Volume1,318,117

P/E (TTM)—

EPS$-0.32

Dividend Yield—

Beta—

Revenue Growth91.60%

About

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.

Healthcare · Medical Devices

7 employees

www.ftzy.com.cn